182 studies found for:    regeneron
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
Condition: Macular Edema Secondary to Central Retinal Vein Occlusion
Interventions: Biological: VEGF Trap-Eye 2.0mg;   Drug: Sham
2 Completed A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain
Condition: Sciatica
Interventions: Drug: REGN475;   Drug: Placebo Injection
3 Recruiting Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Interventions: Drug: Sarilumab;   Drug: Tocilizumab
4 Recruiting Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Condition: Metabolic Disorders
Interventions: Drug: REGN1500;   Drug: placebo
5 Recruiting Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
Condition: Sarcopenia
Interventions: Drug: REGN1033 (SAR391786);   Drug: placebo
6 Not yet recruiting Study of Dupilumab (REGN668/ SAR231893) and Immune Responses in Adults With Atopic Dermatitis (AD)
Condition: Atopic Dermatitis
Interventions: Drug: Dupilumab;   Drug: placebo
7 Recruiting Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers
Condition: Healthy Volunteers
Interventions: Drug: REGN2222(SAR438584);   Drug: placebo
8 Recruiting Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers
Condition: Healthy Volunteers
Interventions: Drug: REGN2009;   Other: placebo
9 Recruiting An Ascending Single-Dose Study of the Safety, Tolerability and Bioeffect of REGN1193
Condition: Healthy Volunteers
Interventions: Drug: REGN1193;   Other: Placebo
10 Not yet recruiting Study of REGN910 in Patients With Diabetic Macular Edema (DME)
Condition: Diabetic Macular Edema
Interventions: Drug: REGN910;   Drug: placebo;   Drug: IVT aflibercept injection
11 Recruiting Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer
Condition: Cancer
Interventions: Drug: REGN1400;   Drug: Erlotinib;   Drug: Cetuximab
12 Recruiting Study to Assess the Safety and Tolerability of Single Doses of REGN1500
Condition: Healthy Volunteers
Interventions: Drug: REGN1500;   Drug: placebo
13 Active, not recruiting The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Intravitreal Aflibercept Injection
14 Completed VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: ziv-aflibercept
15 Completed VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: ziv-aflibercept
16 Completed Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Condition: Cancer
Intervention: Biological: ziv-aflibercept
17 Completed Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Condition: Cancer
Intervention: Biological: ziv-aflibercept
18 Recruiting Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea
Condition: Corneal Neovascularization
Interventions: Drug: Subconjunctival aflibercept;   Other: Placebo: Standard of care only
19 Completed Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD
Condition: Neovascular Age Related Macular Degeneration
Interventions: Drug: VEGF Trap;   Biological: VEGF Trap
20 Terminated Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Condition: Gout
Interventions: Drug: Rilonacept;   Drug: Placebo;   Drug: Allopurinol

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years